Ian Armitage,Martin I. Cooper,Mark D. Eddleston,Neil C. Faiber,Quentin J. McCubbin,Stephen W. Watt
申请号：
US13027523
公开号：
US08653064B2
申请日:
2011.02.15
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention is directed to a compound of formula (I):or a crystalline form thereof, or a solvate thereof to a solid pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula (I), or a crystalline form thereof, or a solvate thereof, and at least one pharmaceutically acceptable carrier or diluent, and to the use of a compound of formula (I), or a crystalline form thereof, or a solvate thereof, for treating a patient suffering from, or subject to, a disease, disorder, or condition mediated by Aurora kinase, and methods related thereto.
